Search results for:
filgrastim
filgrastim
| Drug Name |
Form |
Strength |
Ambulatory Use Only |
Ambulatory Restrictions |
Inpatient Restrictions |
Non-Formulary |
| Nivestym |
SOLUTION, INJECTABLE |
aafi 300 mcg/0.5 mL; 480 mcg/0.8 mL |
|
|
|
|
| Zarxio |
SOLUTION, INJECTABLE |
sndz 300 mcg/0.5 mL; 480 mcg/0.8 mL |
|
|
|
|
| Neupogen |
SOLUTION, INJECTABLE |
300 mcg/0.5 mL; 480 mcg/0.8 mL |
|
|
|
|
Last updated: Jan. 7, 2026
*Alternate biosimilar approved for ambulatory clinics when HFH preferred filgrastim biosimilar (Granix) not covered by insurance. Zarxio 1st line alternate at Jackson only.